The Ebola Outbreak: U.S. Sponsored Bioterror?

By  <http://www.globalresearch.ca/author/jason-kissner> Jason Kissner

Global Research, August 16, 2014

Description: ebola_micrograph_virus-afrique

We can now be extraordinarily confident that the U.S. government is lying,
in key material respects, about the latest Ebola outbreak—and not just
because it lies about nearly everything of political consequence. This
article shows that there are compelling reasons to believe we are being told
three big lies about Ebola. It also offers a simple, rational, yet
disturbing, explanation that very tidily accounts for all three lies. The
explanation supposes that the current Ebola outbreak consists in an act of
U.S.-linked bioterror.

One key U.S. driven lie has to do with the Western MSM’s insistence that
nobody of any repute believes that Ebola might be airborne. On this issue,
the Public Health Agency of Canada remarks
<http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/ebola-eng.php> :

In the laboratory, infection through small-particle aerosols has been
demonstrated in primates, and airborne spread among humans is strongly
suspected, although it has not yet been conclusively demonstrated (1, 6,
13). The importance of this route of transmission is not clear. Poor
hygienic conditions can aid the spread of the virus.

A few scientific studies expressing concern about the airborne possibility
are cited in this article
<http://www.americanthinker.com/2014/08/ebola_optics_and_questionable_msm_sm
iley_narratives_.html> , and other such studies are not hard to find. 

So there are people with authority to speak to the issue who believe that
there is some cause for concern regarding the airborne Ebola prospect, but
the U.S. government/MSM complex instead lies and acts like this isn’t the
case.

Before getting to the second U.S. lie, it is important to mention three
facts that have not received enough discussion. First—and this may be of
pivotal significance–we still have no ideahow Ebolagot to West Africa. See
for yourself <http://en.wikipedia.org/wiki/List_of_Ebola_outbreaks> ;
there’s never been an Ebola outbreak in West Africa before.

Perhaps the racist U.S./MSM view is that all African countries are the same,
so who cares?

Second, the current outbreak, in terms of the number and international
breadth of infections, does seem to be far more contagious than any previous
outbreak; as the previous link shows, we now have at least 1,975 cases. 

Now pause for a moment and take this fully on board: the 1,975 cases exceed
the total number of Ebola cases from 1977 to 2014’s outbreak. So it’s no
surprise that we have, for example, signs of infected individuals in Albania
<http://www.breitbart.com/Big-Peace/2014/08/14/Five-Suspected-Ebola-Victims-
Found-in-Albania> .

The second lie really is a lie of nondisclosure, and concerns the reality
that the MSM has not told us that we are dealing with a biologically
distinct form of Ebola that has never been seen before.

So, consider the following disconcerting information appearing in the New
England Journal of Medicine in April 2014
<http://www.nejm.org/doi/full/10.1056/NEJMoa1404505>  regarding the current
West African, Guinean outbreak of Ebola:

Phylogenetic analysis of the full-length sequences established a separate
clade for the Guinean EBOV strain in sister relationship with other known
EBOV strains. This suggests that the EBOV strain from Guinea has evolved in
parallel with the strains from the Democratic Republic of Congo and Gabon
from a recent ancestor and has not been introduced from the latter countries
into Guinea. Potential reservoirs of EBOV, fruit bats of the species
Hypsignathusmonstrosus, Epomopsfranqueti, & Myonycteristorquata, are present
in large parts of West Africa.18
<http://www.nejm.org/doi/full/10.1056/NEJMoa1404505#ref18>  It is possible
that EBOV has circulated undetected in this region for some time. The
emergence of the virus in Guinea highlights the risk of EBOV outbreaks in
the whole West African subregion.

Furthermore, from the same study:

The high degree of similarity among the 15 partial L gene sequences, along
with the three full-length sequences and the epidemiologic links between the
cases, suggest a single introduction of the virus into the human population.
This introduction seems to have happened in early December 2013 or even
before. 

So, the Guinean variant of Ebola we now confront has been found to be
sufficiently genetically distinct from all previous versions of Ebola that
it has been assigned its own genetic branch, or clade, and it is believed to
have evolved in parallel from an ancestor held in common with a variant of
Ebola native to the Democratic Republic of Congo and Gabon. Moreover, the
current outbreak began not in June or July, but as early as April 2014 and
perhaps even earlier than December, 2013.

And, we seem to have a single introduction of the Guinea (West African)
Ebola variant into the human population. Thus, we seem not to have, for
example, something along the lines of multiple bites of humans by supposedly
Guinea variant Ebola infected fruit bats. 

Finally, the Western Africa Ebola outbreak does not appear to be traceable
to Central Africa or anywhere else, and so we still do not know how Ebola
got to West Africa.

Let us briefly summarize before presenting the third U.S. Ebola lie and
concluding with a reasonable explanation that ties the three lies together. 

The Guinea Ebola variant has never been seen before. It might well be far
more contagious than any Ebola variant hitherto encountered; it could even
be airborne. We still have no idea how Ebola arose in West Africa, but it
did so some time ago—well before the Western MSM started to spew its lies.

Now the third U.S. Ebola lie: In a Matt Drudge-linked article entitled “The
Federal Government
<http://themorningconsult.com/2014/08/federal-governments-ebola-story-rife-i
nconsistencies/> ’s Inconsistent Ebola Story”, we find that the U.S.
government is telling two completely inconsistent stories regarding the
circumstances surrounding delivery of MappPharmaceuticals’ magic ZMapp Ebola
drug to Dr. Kent Brantly and Nancy Writebol. Thus, we have:

According to the CDC, it was Samaritan’s Purse, the private humanitarian
organization that employs Dr. Brantley, who reached out to them in an
attempt to find an experimental Ebola drug. The CDC says it passed
Samaritan’s Purse along to NIH, who referred them to contacts within Mapp.

“This experimental treatment was arranged privately by Samaritan’s Purse,”
the CDC said. “Samaritan’s Purse contacted the Centers for Disease Control
and Prevention (CDC), who referred them to the National Institutes of Health
(NIH). NIH was able to provide the organization with the appropriate
contacts at the private company developing this treatment. The NIH was not
involved with procuring, transporting, approving, or administering the
experimental treatments.”

The New York Times first reported this version of events on Aug. 6, and the
statement was posted on the CDC’s website a few days later,where it remains
<http://www.cdc.gov/vhf/ebola/outbreaks/guinea/qa-experimental-treatments.ht
ml> .

But, as the Morning Consult reports in the same article, we also have:

But the NIH told Morning Consult one of its scientists on the ground in West
Africa approached the charity before the group had even decided to pursue an
experimental alternative.

“The NIH scientist who was in West Africa referred Samaritan’s Purse to
company contacts because they were best equipped to answer questions about
the status of their experimental treatment,” the agency said in an email to
Morning Consult. “This occurred before Samaritan’s Purse decided to pursue
an experimental therapy.”

A statement from Samaritan’s Purse also conflicts with the CDC’s telling of
events, and indicates the NIH and other government agencies may have played
an active role in procuring the drugs.

“The experimental medication given to Dr. Brantley was recommended to us,”
the group said. “We didn’t seek it out, but worked with the National
Institutes of Health and other government agencies to obtain this
medication.”

Hence, we have the U.S. government saying both that delivery of the drug to
the aid workers was initially government’s idea, and that it wasn’t
initially government’s idea. Since both of these possibilities cannot be
true, we have our third U.S. federal Ebola lie. 

But whose idea was it, really, to deliver the ZMapp magic serum (which is
said
<http://abcnews.go.com/Health/experts-surprised-ebola-infected-doctor-walk-h
ospital/story?id=24820682> to have begun reversing Brantly’s condition
within 20 minutes to an hour)? In all likelihood it was the U.S.
government’s idea, at a minimum for the following reason mentioned in the
Morning Consult article: 

If [Mapp] did this on their own, they must have had unbelievable confidence
in the product and lawyers who know this up and down,” Vox said. “If they
went this alone, their investors should be worried, because that’s reckless.
A team of scientists could get in a lot of trouble doing that, and I can’t
imagine they run their company that way, especially considering they have
support from the Department of Defense.

Let’s put all of the above together and move toward wrapping matters up.We
have what appears to be the most contagious variant of Ebola ever
encountered, its genetic form is novel in important respects, and we still
have no idea how it arose in West Africa. 

Yet, we are told that an experimental drug, ZMapp—produced by a previously
unheard of U.S. firm with U.S. Department of Defense ties—is functioning in
miraculous fashion. Furthermore, the U.S. government cannot keep its story
straight about who initiated the delivery of the experimental drug to the
U.S. aid workers, but there are compelling reasons to suppose it was the
U.S. government that engineered the delivery. 

All of the foregoing should prompt us to ask: When was Mapp Pharmaceutical’s
magic drug ZMappdeveloped?

The following language, drawn from an article at International Business
Times
<http://www.ibtimes.co.uk/ebola-zmapp-what-secret-serum-that-cured-american-
doctor-kent-brantly-1459856> , might provide guidance:

A statement from Mapp said: 

“ZMapp is the result of a collaboration between Mapp Biopharmaceutical Inc,
LeafBio, DefyrusInc, the US government and Public Health Agency of Canada.

“ZMapp is composed of three ‘humanised’ monoclonal antibodies manufactured
in plants, specifically Nicotiana. It is an optimised cocktail combining the
best components of MB-003 and ZMAb.

“ZMapp was first identified as a drug candidate in January 2014 and has not
yet been evaluated for safety in humans. As such, very little of the drug is
currently available. Any decision to use an experimental drug in a patient
would be a decision made by the treating physician under the regulatory
guidelines of the FDA.

One very interesting thing to note is the parties involved in producing
ZMapp. Two of the parties are the U.S. government and the Public Health
Agency of Canada—and the Public Health Agency of Canada, you will recall, is
the very same agency that “strongly suspects” that Ebola might be airborne
(see the second paragraph of this article). Yet, we are constantly told the
U.S. government suspects no such thing.

But there are even more important things to consider.

Does “ZMapp was first identified as a drug candidate in January 2014” mean
that ZMappwas designed from the ground up, pretty much when the outbreak
began, with the specific purpose of treating the Guinea Ebola variant (see
above for timing of the outbreak)? Or, does it mean that ZMapp was
repurposed in some way to grapple with the Guinea variant? Or does it
perhaps mean something else entirely?

In any event, if the above MappPharmaceuticals statement is true, this much
is perfectly clear: a major decision about ZMapp and its potential efficacy
was made in January 2014, and that decision appears to have been made very
close on the heels of the beginning of the current Guinea Ebola outbreak. 

Therefore, if ZMapp really is the miraculous success it is purported to be
<http://www.nbcnews.com/storyline/ebola-virus-outbreak/american-ebola-patien
t-dr-kent-brantly-i-am-recovering-every-n181661> , we are given to believe
that, in Research and Development terms, results must have been achieved
virtually overnight. This is because with the beginning of the outbreak of
the brand newGuinea Ebola variant dated to around December 2013, Mapp could
not possibly have had much time before its January 2014 decision to target
the Guinea Ebola variant with ZMapp. 

Or might Mappin fact have had plenty of time?

One possibility is that Mappdid have plenty of time, because it knew about
the brand new Ebola variant before its debut appearance in West Africa. This
would be very strong evidence of a bioterror conspiracy, would it not? Of
course, we are very far from sure about this prospect.

However, even if we are to believe that Mapp did not know about the novel
Guinea Ebola variant before that variant’s first appearance, but did in fact
advance anyway with ZMapp againstthe Guinea variant in January 2014, wemust
still ask exactly how ZM appended up being effective against a brand new
variant Mapp would, under the present assumption, have only just
encountered. 

Perhaps Mapp had been in the process of designing ZMapp so that it could
successfully attack already extant Ebola variants, and whatever properties
made it effective against those already extant variants also transferred to
the novel Guinea variant?

Maybe.

But if that is so, ZMapp should prove successful against variants of Ebola
other than the Guinea variant. Will it?

If it doesn’t prove successful against variants of Ebola other than the
Guinea variant, I do not see how one can logically avoid the conclusion that
the West African rooted, Guinea variant of Ebola amounts to U.S. government
linked bioterror.

Unless, of course, one is willing to invoke what amounts to a miraculous
stroke of luck consisting in the design of a solution that successfully
attacks something that’s never been seen before and was not anticipated—even
though the solution fails against related versions of the same problem.

In closing, please note that the U.S. act of bioterror explanation
economically accounts for all three U.S. lies discussed in the article. It
explains why the U.S. government is lying about the airborne status of
Ebola, why the U.S. government/MSM hybrid is in no hurry to disclose the
geographical and virological novelties of the Guinea variant, and, finally,
why the U.S. government, out of one side of its mouth, wants to act like its
“miracle experimental drug” had to be pried out of its greedy and
comprehensive regulatory hands.

It must be stated, though, that there is one last possibility after all,
which is that the Dr. Kent Brantly miracle recovery is no real recovery at
all.

Dr. Jason Kissner is Associate Professor of Criminology at California State
University. Dr. Kissner’s research on gangs and self-control has appeared in
academic journals. His current empirical research interests include active
shootings. You can reach him [email protected]
<mailto:[email protected]> .

 


Global Research Related Articles


 
<http://www.globalresearch.ca/the-ebola-virus-pandemic-a-weapon-of-mass-dest
ruction/5394976> Description: The Ebola Virus Pandemic: "A Weapon of Mass
Destruction"?The Ebola Virus Pandemic: "A Weapon of Mass Destruction"?This
year’s first outbreak of the hemorrhagic fever virus Ebola started in
February in the West African nation of Guinea. It then began spreading to
Liberia and, for the first time, to Sierra Leone and now Nigeria. With the
...
<http://www.globalresearch.ca/why-does-the-cdc-own-a-patent-on-ebola-inventi
on/5395727> Description: Why Do the U.S. Centers for Disease Control (CDC)
Own a Patent on Ebola "Invention?"Why Do the U.S. Centers for Disease
Control (CDC) Own a Patent on Ebola "Invention?"The U.S. Centers for Disease
Control owns a patent on a particular strain of Ebola known as "EboBun."
It's patent No. CA2741523A1 and it was awarded in 2010. You can view it
here. (Thanks to Natural News readers who ...
<http://www.globalresearch.ca/what-are-us-biological-warfare-researchers-doi
ng-in-the-ebola-zone/5394582> Description: West Africa: What are US
Biological Warfare Researchers Doing in the Ebola Zone?West Africa: What are
US Biological Warfare Researchers Doing in the Ebola Zone?This is a call for
an immediate, thorough, and independent investigation of Tulane University
researchers (see here and here ) and their Fort Detrick associates in the US
biowarfare research community, who have been operating in West Africa during
... 

 

                    Thé Mulindwas Communication Group
"With Yoweri Museveni, Ssabassajja and Dr. Kiiza Besigye, Uganda is in
anarchy"
                    Kuungana Mulindwa Mawasiliano Kikundi
"Pamoja na Yoweri Museveni, Ssabassajja na Dk. Kiiza Besigye, Uganda ni
katika machafuko"

 

_______________________________________________
Ugandanet mailing list
[email protected]
http://kym.net/mailman/listinfo/ugandanet

UGANDANET is generously hosted by INFOCOM http://www.infocom.co.ug/

All Archives can be found at http://www.mail-archive.com/[email protected]/

The above comments and data are owned by whoever posted them (including 
attachments if any). The List's Host is not responsible for them in any way.
---------------------------------------

Reply via email to